Who is Xellia? Xellia Pharmaceuticals is a specialty phar- maceutical company providing important anti-infective treatments against serious and often life-threatening infections. Xellia is wholly owned by Novo Holdings A/S and has state- of-the-art manufacturing facilities located in Denmark, Hungary, China, and the U.S. Time-Consuming Paper-Based T esting Process As a global pharmaceutical manufacturer , Xellia is under constant scrutiny from regulators. The Food and Drug Administration (FDA) en- sures the quality of drug products by carefully monitoring manufacturers’ compliance with its Current Good Manufacturing Practice (cGMP) regulations. The cGMP regulations for drugs make sure that a product is safe for use, and that it has the ingredients and strength it claims to hav

Join for free to read